High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors-Reference-Cited by-同舟云学术

High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors

Published:2009-07-01 Issue:13 Volume:115 Page:2956-2963
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Butturini Anna M.,Jacob Mary,Aguajo Jennifer,Vander-Walde Noam A.,Villablanca Judy,Jubran Rima,Erdreich-Epstein Anat,Marachelian Araz,Dhall Girish,Finlay Jonathan L.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience;Fangusaro;Pediatr Blood Cancer.,2008

2. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma;Chi;J Clin Oncol.,2004

3. Outcome of children less than 3 years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols: final report;Dhall;Proc Soc Clin Oncol.,2007

4. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors;Finlay;J Clin Oncol.,1996

5. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors;Gururangan;J Clin Oncol.,1998

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective re-induction regimen for children with recurrent medulloblastoma;Neuro-Oncology Advances;2024-01-01

2. Long-term Outcomes of Protocol-based Treatment for Newly Diagnosed Medulloblastoma;Cancer Research and Treatment;2023-11-30

3. Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment;Cancers;2021-12-28

4. Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial;Pediatric Blood & Cancer;2021-04-12

5. Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors;International Journal of Clinical Oncology;2019-07-27